|Molecular Vision 2007;
Received 31 March 2007 | Accepted 8 July 2007 | Published 12 July 2007
Effect of intraocular surgery and ketamine on aqueous and serum cytokines
Kyaw Lin Tu,1
Stephen B. Kaye,1
1St Paul's Eye Unit, 2Anaesthetic Department, and the 3Department of Clinical Biochemistry and Metabolic Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom
Correspondence to: Stephen B. Kaye, St Paul's Eye Unit, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Prescot Street, Liverpool, L7 8XP, United Kingdom; Phone: 0044 151 7062134; FAX: 0044 151 7065861; email: firstname.lastname@example.org
Purpose: To determine the effect of intraocular surgery and anesthesia on aqueous and serum cytokines.
Methods: Patients undergoing routine cataract surgery under general and local (peribulbar) anesthesia were randomized to those given general anesthetic with and without the use of ketamine and those having local anesthesia. Aqueous and serum levels of cytokines were collected at commencement of surgery and were determined by an immunoassay using multi-analyte biochip array technology at 18 h post-operatively.
Results: At 18 h postoperative, all patients (37) showed significant and many fold increases in their aqueous levels of interleukin (IL)-1α, IL-1β, IL-4, IL-6, IL-8, vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-α, interferon (IFN)-γ, epidermal growth factor (EGF), and monocyte chemotactic protein (MCP)-1. There was little to no increase in IL-2 and IL-10. Significant increases in some cytokines (EGF, IL-6, and IFN-γ) in the serum were also found (p=0.038). There were no significant differences in aqueous cytokine levels following the use of ketamine or between those patients who had general and local anesthesia (0.11<p<0.97).
Conclusions: There is an aqueous and serum cytokine response following intraocular surgery whether local (peribulbar) or general anesthesia is used. Of the aqueous cytokines measured, three different patterns of responses emerged at 18 h post-cataract surgery; those that were highly increased (IL-8, IL-6, IFN-γ, and TNF-α), medium increase (IL-1β, VEGF, IL-4, and MCP-1), and those with little to no change (EGF, IL-1α, IL-2, and IL-10).
Intraocular surgery commonly results in postoperative intraocular inflammation. This is thought to result from trauma to ocular structures, disruption of the blood barrier, an immune hypersensitivity reaction, or an infective-immune response. This inflammatory response plays an important role in the outcome of a variety of surgical procedures, for example, it may be associated with a reduction in survival of a transplanted cornea , predisposition to cystoid macular edema , or a failure of glaucoma filtration surgery . Control of the inflammatory response is, therefore, likely to be important in determining the success of surgery. Characterization of aqueous cytokines may be helpful in staging disease activity and in correlating cytokine profiles with clinical signs [4-8]. The cytokine response may be important in endothelial loss following intraocular surgery. For example, whereas IL-8 and IL-10 have roles in suppressing inflammation and aid vascular endothelial cell survival [9,10], TNF, IL-6, and IFN-γ are linked with vascular endothelial cell apoptosis [11,12]. Although there have been few studies on the cytokine response to intraocular surgery, IL-6 is likely to be a key mediator of postoperative uveitis and has been shown in both animal  and human  studies to significantly increase following intraocular surgery.
Cardiopulmonary bypass (CPB) has been proposed as a model for systemic inflammatory response syndrome [15,16]. The anesthetic agent, ketamine, has been found to attenuate the IL-6 response after cardiopulmonary bypass (CPB) . Thus far, it is not known if the systemic anti-inflammatory effect of ketamine extends to the eye to cause suppression of post-ocular surgery inflammation. Although systemic (plasma) concentrations of IL-1β, TNF-α, and IL-8 have been found to increase following both general and local anesthesia for cataract surgery , these, as well as other aqueous cytokines, have not been measured in the aqueous humor following intraocular surgery. Therefore, we sought to characterize the cytokine response to intraocular surgery using cataract surgery as the model and to determine whether ketamine had a similar effect found with systemic inflammation.
Patients undergoing routine uncomplicated cataract surgery either under general or local (peribulbar) anesthesia were enrolled into the study after obtaining their informed consent. The decision whether surgery was to be carried out under general or local anesthesia had been determined independently by the patient's ophthalmologist and was unrelated to potential inclusion in this study. The study protocol was approved by the local Research Ethics Committee and the Declaration of Helsinki was adhered to. Patients were excluded if they were using or had used immunosuppressive medication, were using topical ophthalmic medication, had a history of autoimmune disease or other systemic inflammatory disease within the past 5 years, or had a known hypersensitivity to ketamine. Patients were not excluded if they had controlled, non-insulin dependent diabetes mellitus and had not had or required retinal laser treatment. Patients were randomly selected from three groups: those undergoing cataract surgery under general anesthesia with ketamine (GA+ or group 1), those without ketamine (GA- or group 2), and those having local (peribulbar) anesthesia without ketamine (LA or group 3).
Standard small incision (3.2 mm) cataract surgery using phacoemulsification was performed by four experienced cataract surgeons. Preoperative assessment of cataract density was made by a single surgeon using the LOCSIII grading system . The length of the procedure, phacoemulsification time and power, and untoward events during the procedure such as iris touch or hemorrhage were recorded. All patients received the same preoperative topical medication, namely guttae cyclopentolate 1% and phenylephrine 2.5%. A subconjunctival injection of gentamicin 5 mg was given at the end of the procedure. Towards the end of the study, patients received intracameral vancomycin (1 mg in 0.1 ml) in line with changed departmental antimicrobial prophylaxis protocol for cataract surgery. Postoperative topical medication was a reducing regime of guttae betamethasone 0.4% and chloramphenicol 0.5%. Postoperative treatment was not commenced until the 18 h sample had been collected.
All patients had cataract surgery on a Thursday afternoon theatre list (2-5 p.m.). General anesthesia was induced intravenously with a bolus dose of propofol 1-2 mg/Kg and was maintained using volatile vapor of isoflurane 1% in an oxygen and nitrous oxide mixture. Fentanyl (1 μg/Kg) provided analgesia and atracurium (0.5 mg/Kg) was used to provide neuromuscular blockade and to facilitate ventilation and oxygenation. Ketamine (1 mg/Kg) was administered by an I.V. infusion over the duration of the surgery. Postoperatively, cocodamol was administered orally every six h, as required, to alleviate pain. Local anesthesia was administered by a peribulbar injection of 5 ml of a mixture of Lignocaine 2% and Levobupivacaine 0.5%.
Aqueous and serum samples were collected on the first postoperative morning (9-11 a.m.), approximately 18 h from the time of their cataract surgery. Five milliliters of venous blood and 100 μl of aqueous (obtained through the cataract side port incision) were obtained at the commencement of surgery and prior to the administration of ketamine. The side port incision was placed anterior to the limbus to avoid any bleeding. The postoperative samples (aqueous and venous blood) were collected at 18 h postoperatively. The postoperative aqueous sample was collected as follows. Following topical anesthesia with guttae proxymethocaine, the side port site was dabbed with a cotton bud dipped in a 5% betadine solution. Using slit lamp biomicroscopy, a Pierce hydrodissection cannula attached to a 1 ml tuberculin syringe was inserted by one operator into the side port incision flush with the internal opening into the anterior chamber. Then, the second operator withdrew 30-50 μl of aqueous humor; the amount of aqueous withdrawn was determined by monitoring the depth of the anterior chamber. All samples were stored at -80 °C for subsequent analysis.
Clinical outcome measures
Intraocular inflammation was assessed preoperatively and at 18 h by grading the anterior chamber flare (F) from one to four and counting the number of cells (C) in a 0.2 mm beam under 25X magnification. Complications during sampling, postoperative complications, and visual acuity of patients were recorded.
Analysis of samples
Levels of interleukins (IL) -1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, vascular endothelial growth factor (VEGF), tumor necrosis factor-α (TNF-α), interferon-γ(IFN-γ), epidermal growth factor (EGF), and monocyte chemotactic protein-1 (MCP-1) were measured using a Biochip Array System  (Evidence Investigator, Randox Ltd, Co. Antrim, N. Ireland). The biochip is a solid substrate with multiple specific cytokine antibodies attached at predefined sites on the surface. Each cytokine binds to its specific antibody then appropriate enzyme-labeled second antibodies are added and the cytokines are quantified by chemiluminescence using a CCD camera and imaging system. Samples were thawed immediately before analysis, diluted 1:3 if necessary to ensure a volume greater than 100 μl, and 100 μl of the samples were applied directly to each reaction well in the Biochip. Samples were analyzed in two batches where all samples from the same patient were analyzed in the same batch. The between-batch variability for all analytes was less than 12% and within-batch variability less than 10%. As there is little information available on the aqueous concentration of some of the cytokines, it was not possible to determine the most appropriate dilution for sample analysis.
For some of the cytokines, it was not possible to determine the lower or upper values due to lack of sufficient sample for further dilution or concentration. Therefore, the concentrations were ranked, a Friedman test for related samples was used to compare the three groups, and a Kolmogorov-Smirnov test to compare pre to postoperative levels using SPSS (version 14.1) statistical program. A correction factor for multiple testing was made to alpha where indicated.
Fifty-two patients were enrolled into the study. Fifteen patients withdrew from the study prior to taking of second sample and were excluded. Eleven patients (mean age 69 years, female:male=7:4), 11 patients (mean age 74 years, female:male=9:2) and 15 patients (mean age 75 years, female:male=9:6) were categorized into groups 1, 2, and 3, respectively, giving 37 sets of samples (Table 1).
The effective phacoemulsification time (EPT), derived from multiplying average phacoemulsification power and the phacoemulsification time, and the grade of cataract for each patient is included in Table 2 along with the degree of postoperative inflammation. No patient developed any unexpected preoperative complication. Postoperatively, 29 and 8 patients had grade 1 and 2 flare, respectively. Twenty-two, fourteen, and one patients had anterior chamber cell counts of grade 1, 2, and 3, respectively (Table 1). There was no significant difference between the EPT for the three groups, which were 0.75, 0.60, and 0.60 for groups 1, 2, and 3, respectively (p=0.57).
Complications of sampling
One patient each from groups 1 and 2 complained of discomfort and headache following collection of the postoperative aqueous sample at 18 h. In group 3 (LA), one patient's anterior chamber shallowed to approximately 1.5 to 2 mm during the postoperative sampling procedure but reformed satisfactorily after padding of the eye for ten min. All three patients had good visual acuities postoperatively (6/6, 6/5, and 6/9, respectively) with an uneventful clinical course.
The pre and postoperative aqueous cytokine concentrations are included in Table 1.
Apart from IL-1β and EGF, there were detectable levels of the remaining cytokines in the aqueous humor. In particular, all patients had relatively high aqueous levels of MCP-1 and VEGF compared to the remaining other cytokines analyzed. In ten patients (patients 2, 6-8, 12, 22, 30, 33, 34, and 37) aqueous but not serum levels of IL-6 were relatively raised preoperatively (Table 1). Of these ten patients, two had atrophic macular degeneration (one other patient with dry age-related macular degeneration did not have raised aqueous IL-6), two had non-insulin dependent diabetes mellitus, one had had removal of a pterygium three years prior to cataract surgery and one had had a trabeculectomy six years prior to cataract surgery.
Postoperative aqueous cytokine concentrations
Some of the cytokine measurements showed little to no increase while others showed many fold increases. There were significant differences between all of the pre and postoperative aqueous cytokine levels (0.003<p<0.001) except perhaps for IL-2 (p=0.07) and IL10 (p=0.05) especially if alpha is adjusted to 0.005. There were, however, no differences in the pre to postoperative cytokine levels between the three patient groups, GA+, GA-, and LA, for all of the 12 cytokines measured (0.069<p<0.886). Additionally, there was no difference in the change in aqueous cytokines between patients who had general and local anesthesia (0.11<p<0.97). The pre to postoperative changes in concentration could be approximately grouped into three semi-quantitative classes: those showing little to no increase, EGF, IL-1α, IL-2, and IL-10; medium increase, IL-1β, VEGF, IL-4, and MCP-1; and those showing a high (many fold) increase, IL-8, IL-6, IFN-γ, and TNF-α. This is reflected in Figure 1 as the ratio of the post to preoperative aqueous cytokine levels (used for descriptive purposes, the lower and upper limit of detection as appropriate and included in Table 2 as the mean pre and postoperative aqueous cytokine levels). There was no apparent correlation between the EPT and the ratio of post to preoperative aqueous cytokine ratios (0.06<p<0.87).
Serum cytokine levels
The preoperative and postoperative serum levels for the cytokines measured are shown in Figure 2 (ratio of the post to preoperative serum cytokine levels) and included in Table 3. There were small but significant increases in IFN-γ (p=0.005), IL-6 (p=0.02), IL-8 (p=0.03), VEGF (p=0.003), and TNF-α (p=0.013). Although, if alpha is adjusted to 0.005 to correct for multiple testing (ten cytokines), these effects can only be considered preliminary. For the aqueous concentrations, there were no significant differences in the pre and postoperative serum levels between the three groups (0.20<p<0.96). Three patients (two GA-, one GA+) had relatively raised preoperative serum but not aqueous IL-6 levels. No systemic reasons for the raised preoperative serum IL-6 levels were identified.
Methodologies for studying the cellular infiltration and the presence of various cytokines in aqueous humor range from conventional assay methods like ELISA (and sequential ELISA) to techniques such as flow cytometric multiplex array (CBA) [21,22] and multiple bead immunoassay . More recently, biochips using protein array technology have made possible, simultaneously, detection of multiple analytes, reduction in sample and reagent volumes, and high output of test results. Intra- and inter-assay imprecision for most of the analytes in this study was <10% and comparison studies have shown compatible results with other methods for measurement of cytokines . Because the samples were batch tested and there was a limited amount of sample (40 μl), it was not possible to determine the optimum dilution for each cytokine. This resulted in the difficulty in determining the precise concentration for some cytokines, hence, there was a cut-off, for example, at either less than 0.1 or greater than 350 pg/ml. Nevertheless the post to preoperative changes were often many fold greater. Although every attempt was made to immediately store the samples, it is possible that there was degradation of the cytokines prior to storage and as the sample warmed, its concentration was altered. The ratio of post to preoperative concentrations should, however, be reflective of the surgical effect. Although it would have been useful to measure total protein concentration, all of the aqueous samples were used up to meet the volume requirements for the Biochip assays. While it is likely that there may have been a change in aqueous protein concentration from preoperative to postoperative, the changes in cytokines were so great that the pre to postoperative results remain valid. Similarly, the cytokine concentrations relative to each would be the same.
The 18 h postoperative time point was chosen because it was the most convenient for the patient and also because cytokine concentrations based on IL-6 have been found to be high at this time . Clearly, because only two time points were sampled, little inferences can be made. Nevertheless, of the 12 cytokines analyzed in this study, all except EGF were detectable in the aqueous preoperatively and all except IL-2 and IL-10 showed significant increases 18 h following surgery. In all of the study groups, aqueous cytokine levels broadly showed three different patterns of response at 18 h postoperatively: those showing a high increase, IL-8, IL-6, IFN-γ, and TNF-α; those showing a medium increase, IL-1β, VEGF, IL-4, and MCP-1; and those showing little or no increase, EGF, IL-1α, IL-2, and IL-10. Thus, as far as aqueous levels are concerned, predominantly macrophage-derived cytokines (TNF-α, IL-1β, IL-6, IL-8, and MCP1) and predominantly endothelial cell-derived cytokines (VEGF, TNF-α, IL-6, IL-8, and MCP) showed several fold increases. This may be reflecting a breakdown in the blood-aqueous barrier. The results for IL-6 are similar to those of Malacaze et al who reported low to undetectable preoperative aqueous IL-6 levels with several fold increases three days following extracapsular cataract surgery with no detectable IL-6 bioactivity in the serum .
General anesthesia using Fentanyl, Thiopentone, Isoflurane, Propofol, and nitrous oxide has been associated with an increase in IFN-γ, IFN-α, TNF-α, and soluble interleukin-2 receptor synthesis, but not in IL-1β and IL-6 . Anesthetic technique can modify the balance of cytokines associated with surgery [24,25]. Ketamine, an intravenous anesthetic agent, had been found to have suppressive effects on macrophage functions including inflammatory cytokine production possibly via reduction of mitochondrial membrane potential in cell culture . It has also been shown to suppress staphylococcal enterotoxin B-induced proinflammatory cytokine production in human whole blood . In our study, patients having surgery under GA received a bolus injection of Propofol or an infusion of 1 mg/Kg of ketamine. We found no suppressive effect of Propofol on TNF-α levels as has been reported in studies on rats . Similarly, with regard to ketamine, the absence of a detectable effect on aqueous or serum cytokine responses may reflect poor penetration of ketamine into the eye, peculiarity of eye surgery, or insufficient therapeutic levels. Although in rats the minimum effective dose to inhibit IL-6 secretion is between 5-10 mg/Kg [29,30], the dose used in our study (1 mg/Kg) was higher than that used by Roytblat et al. (0.25 mg/Kg) who noted an attenuation of postoperative serum IL-6 levels in the patients given ketamine in a study on patients undergoing cardio-pulmonary bypass . Although cataract surgery would not be expected to cause a major systemic insult, serum cytokine levels also showed a slight but significant increase following surgery, reflecting some systemic effect or release into the circulation. We could not detect any differences between general or local anesthesia in terms of the clinical or cytokine response. Although increases in IL-1β, IL-6, and IL-8 are attenuated by high doses of lidocaine in high concentrations (0.5 mg/ml) , this level is unlikely to be reached in the anterior chamber following peribulbar injection.
It has previously been reported that greater phacoemulsification energy is required for higher grades of nuclear color (NC) and nuclear opalescence (NO) as graded by the Lens Opacities Classification System, version III (LOCSIII) . Although not a primary outcome measure and therefore speculative, the absence of a detectable correlation between aqueous cytokine response and effective phacoemulsification time/energy suggests that the aqueous cytokine response at 18 h bears little correlation with the amount of phacoemulsification energy within the range used. Although the inflammatory cytokine response may be relatively standard for this type of surgery, it may be more marked in complicated or difficult surgical cases thus indicates further work in such cases.
In the absence of additional time point measurements, it is difficult to speculate on the significance of the cytokine responses measured. That is, although our results represent snapshots of aqueous cytokine levels pre and 18 h post cataract surgery, the cytokine response following corneal infection  or trauma  is intense and usually short-lived. Whether the aqueous levels of these cytokines remain elevated postoperatively is clearly important for further surgery such as penetrating keratoplasty following cataract or glaucoma filtration surgery. It would be useful to measure these cytokines as well as TGF-β at other postoperative time points, particularly later time points, to determine the response pattern and maintenance of the response. Although there is between subject variation, the response (at least at 18 h) appears reasonably uniform so that different patient groups could be selected for different time intervals which would mean repeated individual testing is unnecessary. In addition, it would be informative to measure the cytokine response in cases where the postoperative inflammatory response has been greater than expected and to correlate or standardize with the total aqueous protein concentration. In conclusion, we have found that aqueous cytokine levels showed three different patterns of response at 18 h post-cataract surgery; those that were highly increased (IL-8, IL-6, IFN-γ, and TNF-α), intermediately increased (IL-1β, VEGF, IL-4, and MCP-1), and those with little to no change (EGF, IL-1α, IL-2, and IL-10). This response appears to be unaffected by the use of ketamine.
This study was supported by the Anterior Segment Fund of the Royal Liverpool Hospital. The authors are grateful to Jean Devine, Department of Biochemistry and Metabolic Medicine, Royal Liverpool and Broadgreen University Hospital, for her assistance with handling and analysis of samples.
1. Williams KA, Roder D, Esterman A, Muehlberg SM, Coster DJ. Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. Ophthalmology 1992; 99:403-14.
2. El-Harazi SM, Feldman RM. Control of intra-ocular inflammation associated with cataract surgery. Curr Opin Ophthalmol 2001; 12:4-8.
3. Vote B, Fuller JR, Bevin TH, Molteno AC. Systemic anti-inflammatory fibrosis suppression in threatened trabeculectomy failure. Clin Experiment Ophthalmol 2004; 32:81-6.
4. Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, Hori S. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 2005; 243:3-8.
5. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005; 140:256-61.
6. Funatsu H, Yamashita H, Nakamura S, Mimura T, Eguchi S, Noma H, Hori S. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2006; 113:294-301.
7. Tashimo A, Mitamura Y, Nagai S, Nakamura Y, Ohtsuka K, Mizue Y, Nishihira J. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy. Diabet Med 2004; 21:1292-7.
8. Curnow SJ, Falciani F, Durrani OM, Cheung CM, Ross EJ, Wloka K, Rauz S, Wallace GR, Salmon M, Murray PI. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 2005; 46:4251-9.
9. Chen S, Kapturczak MH, Wasserfall C, Glushakova OY, Campbell-Thompson M, Deshane JS, Joseph R, Cruz PE, Hauswirth WW, Madsen KM, Croker BP, Berns KI, Atkinson MA, Flotte TR, Tisher CC, Agarwal A. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl AcadSci U S A 2005; 102:7251-6.
10. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 2005; 8:63-71.
11. Li JH, Pober JS. The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. J Immunol 2005; 175:1858-66.
12. Seynhaeve AL, Vermeulen CE, Eggermont AM, ten Hagen TL. Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells. Cell Biochem Biophys 2006; 44:157-69.
13. Zhaohui Z, Shouzhi H. An experimental study of the tumour necrosis factor levels in aqueous humor after traumatic cataract and intraocular lens implantation. Chin Med Sci J 1999; 14:64-6.
14. Malecaze F, Chollet P, Cavrois E, Vita N, Arne JL, Ferrara P. Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study. Arch Ophthalmol 1991; 109:1681-3.
15. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993; 56:S92-6.
16. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 1992; 20:1090-6.
17. Roytblat L, Talmor D, Rachinsky M, Greemberg L, Pekar A, Appelbaum A, Gurman GM, Shapira Y, Duvdenani A. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 1998; 87:266-71.
18. Goto Y, Ho SL, McAdoo J, Fanning NF, Wang J, Redmond HP, Shorten GD. General versus regional anaesthesia for cataract surgery: effects on neutrophil apoptosis and the postoperative pro-inflammatory state. Eur J Anaesthesiol 2000; 17:474-80.
19. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993; 111:831-6.
20. Fitzgerald SP, Lamont JV, McConnell RI, Benchikh el O. Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 2005; 51:1165-76.
21. Ooi KG, Galatowicz G, Towler HM, Lightman SL, Calder VL. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFNgamma profiles in uveitis. Invest Ophthalmol Vis Sci 2006; 47:272-7.
22. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, Campos R, Ernst D, Gaur A. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004; 110:252-66.
23. Brand JM, Kirchner H, Poppe C, Schmucker P. [Cytokine release and changes in mononuclear cells in peripheral blood under the influence of general anesthesia]. Anaesthesist 1998; 47:379-86.
24. Gilliland HE, Armstrong MA, Carabine U, McMurray TJ. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth Analg 1997; 85:1394-8.
25. Schneemilch CE, Ittenson A, Ansorge S, Hachenberg T, Bank U. Effect of 2 anesthetic techniques on the postoperative proinflammatory and anti-inflammatory cytokine response and cellular immune function to minor surgery. J Clin Anesth 2005; 17:517-27.
26. Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol 2005; 204:27-35.
27. Kawasaki C, Kawasaki T, Ogata M, Nandate K, Shigematsu A. Ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood. Can J Anaesth 2001; 48:819-23.
28. Gao J, Zeng BX, Zhou LJ, Yuan SY. Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 2004; 92:277-9.
29. Taniguchi T, Kanakura H, Takemoto Y, Kidani Y, Yamamoto K. Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats. Tohoku J Exp Med 2003; 200:85-92.
30. Sun J, Wang XD, Liu H, Xu JG. Ketamine suppresses intestinal NF-kappa B activation and proinflammatory cytokine in endotoxic rats. World J Gastroenterol 2004; 10:1028-31.
31. Lan W, Harmon DC, Wang JH, Shorten GD, Redmond PH. Activated endothelial interleukin-1beta, -6, and -8 concentrations and intercellular adhesion molecule-1 expression are attenuated by lidocaine. Anesth Analg 2005; 100:409-12.
32. Davison JA, Chylack LT. Clinical application of the lens opacities classification system III in the performance of phacoemulsification. J Cataract Refract Surg 2003; 29:138-45.
33. Yamagami S, Yokoo S, Mimura T, Amano S. Effects of TGF-beta2 on immune response-related gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci 2004; 45:515-21.
34. Xue ML, Zhu H, Willcox M, Wakefield D, Lloyd A, Thakur A. The role of IL-1beta in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization. Curr Eye Res 2001; 23:406-14.